Hassan, Mais Salah, and Ali Mohammed Jawad. “Assessment of Pathological Response to Neoadjuvant Therapy: Comparison Between Pertuzumab-Based and Non-Pertuzumab Protocols in HER2-Positive Breast Cancer”. Middle Eastern Cancer and Oncology Journal 2, no. 3 (July 12, 2026): 1–9. Accessed November 9, 2026. https://scientificsteps-group.com/ojs/ojs3/index.php/mecoj/article/view/229.